Paul Streck
Chief Tech/Sci/R&D Officer at ALBIREO PHARMA, INC.
Profile
Paul D.
Streck is currently the Chief Medical Officer at Albireo Pharma, Inc. He previously held positions as Director-Marketing at Amgen USA, Inc. in 2006-2007, Group Vice President at Shire Plc in 2013-2015, Chief Medical Officer at Insmed, Inc. in 2017-2019, Chief Medical Officer & SVP-Clinical Development at Arena Pharmaceuticals, Inc. in 2020-2022, Group Vice President at GSK Plc, and Chief Medical Officer at Lundbeck Seattle BioPharmaceuticals, Inc. Dr. Streck received his undergraduate degree from Rutgers State University of New Jersey, his graduate degree from Sidney Kimmel Medical College, and his MBA from The Fuqua School of Business.
Paul Streck active positions
Companies | Position | Start |
---|---|---|
ALBIREO PHARMA, INC. | Chief Tech/Sci/R&D Officer | 2022-12-18 |
Former positions of Paul Streck
Companies | Position | End |
---|---|---|
ARENA PHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 2022-03-10 |
INSMED INCORPORATED | Chief Tech/Sci/R&D Officer | 2019-01-17 |
SHIRE | Corporate Officer/Principal | 2015-10-31 |
Amgen USA, Inc.
Amgen USA, Inc. BiotechnologyHealth Technology Part of Amgen, Inc., Amgen USA, Inc. is a private company that manufactures biological products. The company is based in Thousand Oaks, CA. | Sales & Marketing | 2007-09-30 |
GSK PLC | Corporate Officer/Principal | - |
Training of Paul Streck
Rutgers State University of New Jersey | Undergraduate Degree |
Sidney Kimmel Medical College | Graduate Degree |
The Fuqua School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
INSMED INCORPORATED | Health Technology |
GSK PLC | Health Technology |
Private companies | 5 |
---|---|
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
Amgen USA, Inc.
Amgen USA, Inc. BiotechnologyHealth Technology Part of Amgen, Inc., Amgen USA, Inc. is a private company that manufactures biological products. The company is based in Thousand Oaks, CA. | Health Technology |
- Stock Market
- Insiders
- Paul Streck